List of All Referred Studies

List of all referred studies

Abe, K., M. Okano, and H. Sasaki. "Phenytoin Elimination Kinetics in Two Children with Drug Intoxication." Eur J Pediatr 135, no. 1 (1980): 69-71.

Adityanjee. "The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (Silent)." Pharmacopsychiatry 22, no. 2 (1989): 81-3.

Adityanjee, K. R. Munshi, and A. Thampy. "The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity." Clin Neuropharmacol 28, no. 1 (2005): 38-49.

Agrawal, B. L. "Ataxia Caused by Fluoxymesterone Therapy in Breast Cancer." Arch Intern Med 141, no. 7 (1981): 958-9.

Alioglu, Z., A. Sari, S. K. Velioglu, Ouml, and M. zmenoglu. "Cerebellar Atrophy Following Acute Phenytoin Intoxication." J Neuroradiol 27, no. 1 (2000): 52-5.

Alkawi, A., J. C. Kattah, and K. Wyman. "Downbeat Nystagmus as a Result of Lamotrigine Toxicity." Epilepsy Res 63, no. 2-3 (2005): 85-8.

Andrade, C., B. N. Gangadhar, and S. M. Channabasavanna. "Pathological Neurotoxicity with Lithium." Indian J Psychiatry 29, no. 3 (1987): 279-81.

Anhut, H., P. Ashman, T. J. Feuerstein, W. Sauermann, M. Saunders, and B. Schmidt. "Gabapentin (Neurontin) as Add-on Therapy in Patients with Partial Seizures: A Double-Blind, Placebo-Controlled Study. The International Gabapentin Study Group." Epilepsia 35, no. 4 (1994): 795-801.

Apte, S. N., and J. W. Langston. "Permanent Neurological Deficits Due to Lithium Toxicity." Ann Neurol 13, no. 4 (1983): 453-5.

Ardalan, B., G. Singh, and H. Silberman. "A Randomized Phase I and Ii Study of Short-Term Infusion of High-Dose Fluorouracil with or without N-(Phosphonacetyl)-L-Aspartic Acid in Patients with Advanced Pancreatic and Colorectal Cancers." J Clin Oncol 6, no. 6 (1988): 1053-8.

Arezzo, J. C., J. Rosenstock, L. Lamoreaux, and L. Pauer. "Efficacy and Safety of Pregabalin 600 Mg/D for Treating Painful Diabetic Peripheral Neuropathy: A Double-Blind Placebo-Controlled Trial." BMC Neurol 8, (2008): 33.

Armour, D. J., C. Fidler, E. C. Wright, and S. Balarajan. "Vigabatrin in Adults with Poorly-Controlled Epilepsy and Learning Disabilities." Seizure 1, no. 3 (1992): 157-62.

Arroyo, S., H. Anhut, A. R. Kugler, C. M. Lee, L. E. Knapp, E. A. Garofalo, S. Messmer, and Group Pregabalin -011 International Study. "Pregabalin Add-on Treatment: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study in Adults with Partial Seizures." Epilepsia 45, no. 1 (2004): 20-7.

Arya, D. K. "Lithium-Induced Neurotoxicity at Serum Lithium Levels within the Therapeutic Range." Aust N Z J Psychiatry 30, no. 6 (1996): 871-3.

Atkins, J. N., H. B. Muss, D. Case, J. Brockschmidt, F. M. Schnell, M. O'Rourke, T. H. Grote, J. H. West, S. Anthony, and V. Stanley. "High-Dose 24-Hour Infusion of 5-Fluorouracil in Metastatic Prostate Cancer. A Phase Ii Trial of the Piedmont Oncology Association." Am J Clin Oncol 14, no. 6 (1991): 526-9.

Atkinson, K., J. Biggs, P. Darveniza, J. Boland, A. Concannon, and A. Dodds. "Spinal Cord and Cerebellar-Like Syndromes Associated with the Use of Cyclosporine in Human Recipients of Allogeneic Marrow Transplants." Transplant Proc 17, no. 2 (1985): 1673-5.

Awada, A., P. Amene, M. al Jumah, and K. al Beladi. "[Residual Cerebellar Ataxia Following Acute Phenytoin Intoxication]." Rev Neurol (Paris) 155, no. 4 (1999): 306-8.

Aylett, S. E., H. Cross, and D. Berry. "Eye Rolling as a Manifestation of Clobazam Toxicity in a Child with Epilepsy." Dev Med Child Neurol 48, no. 7 (2006): 612-5.

Baath, N. S., J. Hong, and S. P. Sattar. "Possible Carbamazepine Toxicity with Terbinafine." Can J Clin Pharmacol 13, no. 2 (2006): e228-31.

Baier, W. K., U. Beck, H. Doose, H. Klinge, and W. Hirsch. "Cerebellar Atrophy Following Diphenylhydantoin Intoxication." Neuropediatrics 15, no. 2 (1984): 76-81.

Baier, W. K., U. Beck, and W. Hirsch. "Ct Findings Following Diphenylhydantoin Intoxication." Pediatr Radiol 15, no. 4 (1985): 220-1.

Barcs, G., E. B. Walker, C. E. Elger, A. Scaramelli, H. Stefan, Y. Sturm, A. Moore, G. Flesch, L. Kramer, and J. D'Souza. "Oxcarbazepine Placebo-Controlled, Dose-Ranging Trial in Refractory Partial Epilepsy." Epilepsia 41, no. 12 (2000): 1597-607.

Baulac, M., D. Cavalcanti, F. Semah, A. Arzimanoglou, and J. J. Portal. "Gabapentin Add-on Therapy with Adaptable Dosages in 610 Patients with Partial Epilepsy: An Open, Observational Study. The French Gabapentin Collaborative Group." Seizure 7, no. 1 (1998): 55-62.

Baulac, M., T. Leon, T. J. O'Brien, E. Whalen, and J. Barrett. "A Comparison of Pregabalin, Lamotrigine, and Placebo as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures." Epilepsy Res 91, no. 1 (2010): 10-9.

Baz, D. V., J. S. Bofill, and J. A. Nogueira. "Irinotecan-Induced Dysarthria." J Natl Cancer Inst 93, no. 18 (2001): 1419-20.

Beattie, B., J. Biller, B. Mehlhaus, and M. Murray. "Verapamil-Induced Carbamazepine Neurotoxicity. A Report of Two Cases." Eur Neurol 28, no. 2 (1988): 104-5.

Bechstein, W. O. "Neurotoxicity of Calcineurin Inhibitors: Impact and Clinical Management." Transpl Int 13, no. 5 (2000): 313-26.

Belli, L. S., L. De Carlis, F. Romani, G. F. Rondinara, P. Rimoldi, A. Alberti, G. Bettale, L. Dughetti, G. Ideo, M. Sberna, and et al. "Dysarthria and Cerebellar Ataxia: Late Occurrence of Severe Neurotoxicity in a Liver Transplant Recipient." Transpl Int 6, no. 3 (1993): 176-8.

Ben-Menachem, E., V. Biton, D. Jatuzis, B. Abou-Khalil, P. Doty, and G. D. Rudd. "Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial-Onset Seizures." Epilepsia 48, no. 7 (2007): 1308-17.

Ben-Menachem, E., A. A. Gabbai, A. Hufnagel, J. Maia, L. Almeida, and P. Soares-da-Silva. "Eslicarbazepine Acetate as Adjunctive Therapy in Adult Patients with Partial Epilepsy." Epilepsy Res 89, no. 2-3 (2010): 278-85.

Ben-Menachem, E., O. Henriksen, M. Dam, M. Mikkelsen, D. Schmidt, S. Reid, R. Reife, L. Kramer, G. Pledger, and R. Karim. "Double-Blind, Placebo-Controlled Trial of Topiramate as Add-on Therapy in Patients with Refractory Partial Seizures." Epilepsia 37, no. 6 (1996): 539-43.

Bendiksen, A., and L. M. Larsen. "Convulsions, Ataxia and Hallucinations Following Propofol." Acta Anaesthesiol Scand 42, no. 6 (1998): 739-41.

Beran, R., S. Berkovic, A. Black, G. Danta, J. Dunne, J. Frasca, K. Grainger, C. Kilpatrick, R. McKenzie, D. McLaughlin, G. Schapel, and E. Somerville. "Australian Study of Titration to Effect Profile of Safety (Aus-Steps): High-Dose Gabapentin (Neurontin) in Partial Seizures." Epilepsia 42, no. 10 (2001): 1335-9.

Beran, R. G., S. F. Berkovic, N. Buchanan, G. Danta, R. Mackenzie, G. Schapel, G. Sheean, and F. Vajda. "A Double-Blind, Placebo-Controlled Crossover Study of Vigabatrin 2 G/Day and 3 G/Day in Uncontrolled Partial Seizures." Seizure 5, no. 4 (1996): 259-65.

Beran, R. G., S. F. Berkovic, F. M. Dunagan, F. J. Vajda, G. Danta, A. B. Black, and R. Mackenzie. "Double-Blind, Placebo-Controlled, Crossover Study of Lamotrigine in Treatment-Resistant Generalised Epilepsy." Epilepsia 39, no. 12 (1998): 1329-33.

Bernstein, A. L., and J. L. Leventhal-Rochon. "Neurotoxicity Related to the Use of Topical Tretinoin (Retin-a)." Ann Intern Med 124, no. 2 (1996): 227-8.

Betts, T., G. Goodwin, R. M. Withers, and A. W. Yuen. "Human Safety of Lamotrigine." Epilepsia 32 Suppl 2, (1991): S17-21.

Beydoun, A., B. M. Uthman, A. R. Kugler, M. J. Greiner, L. E. Knapp, E. A. Garofalo, and Group Pregabalin -009 Study. "Safety and Efficacy of Two Pregabalin Regimens for Add-on Treatment of Partial Epilepsy." Neurology 64, no. 3 (2005): 475-80.

Binnie, C. D., R. M. Debets, M. Engelsman, J. W. Meijer, H. Meinardi, J. Overweg, A. W. Peck, A. Van Wieringen, and W. C. Yuen. "Double-Blind Crossover Trial of Lamotrigine (Lamictal) as Add-on Therapy in Intractable Epilepsy." Epilepsy Res 4, no. 3 (1989): 222-9.

Binnie, C. D., W. van Emde Boas, D. G. Kasteleijn-Nolste-Trenite, R. A. de Korte, J. W. Meijer, H. Meinardi, A. A. Miller, J. Overweg, A. W. Peck, A. van Wieringen, and et al. "Acute Effects of Lamotrigine (Bw430c) in Persons with Epilepsy." Epilepsia 27, no. 3 (1986): 248-54.

Biton, V., A. Gil-Nagel, M. J. Brodie, S. E. Derossett, and V. Nohria. "Safety and Tolerability of Different Titration Rates of Retigabine (Ezogabine) in Patients with Partial-Onset Seizures." Epilepsy Res 107, no. 1-2 (2013): 138-45.

Blanche, P., E. Raynaud, D. Kerob, and N. Galezowski. "Lithium Intoxication in an Elderly Patient after Combined Treatment with Losartan." Eur J Clin Pharmacol 52, no. 6 (1997): 501.

Boas, J., M. Dam, M. L. Friis, O. Kristensen, B. Pedersen, and J. Gallagher. "Controlled Trial of Lamotrigine (Lamictal) for Treatment-Resistant Partial Seizures." Acta Neurol Scand 94, no. 4 (1996): 247-52.

Boesen, P., J. Fallingborg, and E. Spaun. "Severe Persistent Cerebellar Dysfunction Complicating Cytosine Arabinoside Therapy." Acta Med Scand 224, no. 2 (1988): 189-91.

Bollen, E., and J. B. Lanser. "Reversible Mental Deterioration and Neurological Disturbances with O,P'-Ddd Therapy." Clin Neurol Neurosurg 94 Suppl, (1992): S49-51.

Bos, M. J., A. W. de Weerd, and E. E. Hagebeuk. "[Staring Episodes in Children with Developmental Disorders: Epilepsy or Behaviour?]." Ned Tijdschr Geneeskd 155, (2011): A2473.

Bosso, J. A., C. A. Liptak, D. K. Seilheimer, and G. M. Harrison. "Toxicity of Colistin in Cystic Fibrosis Patients." DICP 25, no. 11 (1991): 1168-70.

Botez, M. I., J. Gravel, E. Attig, and J. L. Vezina. "Reversible Chronic Cerebellar Ataxia after Phenytoin Intoxication: Possible Role of Cerebellum in Cognitive Thought." Neurology 35, no. 8 (1985): 1152-7.

Brodie, M. J. "Lamotrigine--an Update." Can J Neurol Sci 23, no. 4 Suppl 2 (1996): S6-9.

Brodie, M. J., H. Lerche, A. Gil-Nagel, C. Elger, S. Hall, P. Shin, V. Nohria, H. Mansbach, and Restore Study Group. "Efficacy and Safety of Adjunctive Ezogabine (Retigabine) in Refractory Partial Epilepsy." Neurology 75, no. 20 (2010): 1817-24.

Browne, T. R., R. H. Mattson, J. K. Penry, D. B. Smith, D. M. Treiman, B. J. Wilder, E. Ben-Menachem, R. M. Miketta, K. M. Sherry, and G. K. Szabo. "A Multicentre Study of Vigabatrin for Drug-Resistant Epilepsy." Br J Clin Pharmacol 27 Suppl 1, (1989): 95S-100S.

Buckler, R. A., and J. H. Friedman. "Maprotiline-Induced Ataxia." J Clin Psychopharmacol 6, no. 6 (1986): 382-3.

Cachat, F., and A. Tufro. "Phenytoin/Isradipine Interaction Causing Severe Neurologic Toxicity." Ann Pharmacother 36, no. 9 (2002): 1399-402.

Cereghino, J. J., V. Biton, B. Abou-Khalil, F. Dreifuss, L. J. Gauer, and I. Leppik. "Levetiracetam for Partial Seizures: Results of a Double-Blind, Randomized Clinical Trial." Neurology 55, no. 2 (2000): 236-42.

Cerqueira, A. C., M. C. Reis, F. D. Novis, J. M. Bezerra, G. C. Magalhaes, M. Rozenthal, and A. E. Nardi. "Cerebellar Degeneration Secondary to Acute Lithium Carbonate Intoxication." Arq Neuropsiquiatr 66, no. 3A (2008): 578-80.

Chacko, J., K. Pramod, S. Sinha, J. Saini, A. Mahadevan, R. D. Bharath, P. S. Bindu, T. C. Yasha, and A. B. Taly. "Clinical, Neuroimaging and Pathological Features of 5-Nitroimidazole-Induced Encephalo-Neuropathy in Two Patients: Insights into Possible Pathogenesis." Neurol India 59, no. 5 (2011): 743-7.

Chan, K., and R. G. Beran. "Value of Therapeutic Drug Level Monitoring and Unbound (Free) Levels." Seizure 17, no. 6 (2008): 572-5.

Chappell, A. S., J. W. Sander, M. J. Brodie, D. Chadwick, A. Lledo, D. Zhang, J. Bjerke, G. M. Kiesler, and S. Arroyo. "A Crossover, Add-on Trial of Talampanel in Patients with Refractory Partial Seizures." Neurology 58, no. 11 (2002): 1680-2.

Charness, M. E., F. Morady, and M. M. Scheinman. "Frequent Neurologic Toxicity Associated with Amiodarone Therapy." Neurology 34, no. 5 (1984): 669-71.

Choi, J. Y., Y. M. Park, Y. S. Woo, S. U. Kim, J. M. Jung, and D. Y. Kwon. "Perverted Head-Shaking and Positional Downbeat Nystagmus in Pregabalin Intoxication." J Neurol Sci 337, no. 1-2 (2014): 243-4.

Chung, S., M. R. Sperling, V. Biton, G. Krauss, D. Hebert, G. D. Rudd, P. Doty, and S. P. Study Group. "Lacosamide as Adjunctive Therapy for Partial-Onset Seizures: A Randomized Controlled Trial." Epilepsia 51, no. 6 (2010): 958-67.

Cocito, L., M. Maffini, and C. Loeb. "Long-Term Observations on the Clinical Use of Lamotrigine as Add-on Drug in Patients with Epilepsy." Epilepsy Res 19, no. 2 (1994): 123-7.

Cocito, L., M. Maffini, P. Perfumo, F. Roncallo, and C. Loeb. "Vigabatrin in Complex Partial Seizures: A Long-Term Study." Epilepsy Res 3, no. 2 (1989): 160-6.

Cohen, W. J., and N. H. Cohen. "Lithium Carbonate, Haloperidol, and Irreversible Brain Damage." JAMA 230, no. 9 (1974): 1283-7.

Coldwell, S. E., K. Awamura, P. Milgrom, K. S. Depner, E. Kaufman, K. L. Preston, and H. W. Karl. "Side Effects of Triazolam in Children." Pediatr Dent 21, no. 1 (1999): 18-25.

Conners, G. P. "Piperazine Neurotoxicity: Worm Wobble Revisited." J Emerg Med 13, no. 3 (1995): 341-3.

Coulter, D. M., I. R. Edwards, and R. L. Savage. "Survey of Neurological Problems with Amiodarone in the New Zealand Intensive Medicines Monitoring Programme." N Z Med J 103, no. 885 (1990): 98-100.

Craig, S. "Phenytoin Poisoning." Neurocrit Care 3, no. 2 (2005): 161-70.

Crawford, P., H. Meinardi, S. Brown, T. W. Rentmeester, B. Pedersen, P. C. Pedersen, and L. C. Lassen. "Tiagabine: Efficacy and Safety in Adjunctive Treatment of Partial Seizures." Epilepsia 42, no. 4 (2001): 531-8.

Curtis, D. L., R. Piibe, M. J. Ellenhorn, J. Wasserberger, and G. Ordog. "Phenytoin Toxicity: A Review of 94 Cases." Vet Hum Toxicol 31, no. 2 (1989): 164-5.

Dallocchio, C., C. Buffa, P. Mazzarello, and S. Chiroli. "Gabapentin Vs. Amitriptyline in Painful Diabetic Neuropathy: An Open-Label Pilot Study." J Pain Symptom Manage 20, no. 4 (2000): 280-5.

De Marco, S., E. Squilloni, L. Vigna, M. F. Bertagnolio, and C. N. Sternberg. "Irinotecan Chemotherapy Associated with Transient Dysarthria and Aphasia." Ann Oncol 15, no. 7 (2004): 1147-8.

Dean, C., M. Mosier, and K. Penry. "Dose-Response Study of Vigabatrin as Add-on Therapy in Patients with Uncontrolled Complex Partial Seizures." Epilepsia 40, no. 1 (1999): 74-82.

Dembowski, C., and T. Rechlin. "Successful Antimanic Treatment and Mood Stabilization with Lamotrigine, Clozapine, and Valproate in a Bipolar Patient after Lithium-Induced Cerebellar Deterioration. A Case Report." Pharmacopsychiatry 36, no. 2 (2003): 83-6.

Dennison, U., M. Clarkson, J. O'Mullane, and E. M. Cassidy. "The Incidence and Clinical Correlates of Lithium Toxicity: A Retrospective Review." Ir J Med Sci 180, no. 3 (2011): 661-5.

Dixon, R. A., N. R. Bennett, M. J. Harrison, C. Kenyon, and J. A. Thornton. "I.V. Flunitrazepam and I.V. Diazepam in Conservative Dentistry. A Cross-over Trial." Br J Anaesth 52, no. 5 (1980): 517-26.

Donaldson, I. M., and J. Cuningham. "Persisting Neurologic Sequelae of Lithium Carbonate Therapy." Arch Neurol 40, no. 12 (1983): 747-51.

Dorado, P., E. Lopez-Torres, E. M. Penas-Lledo, J. Martinez-Anton, and A. Llerena. "Neurological Toxicity after Phenytoin Infusion in a Pediatric Patient with Epilepsy: Influence of Cyp2c9, Cyp2c19 and Abcb1 Genetic Polymorphisms." Pharmacogenomics J 13, no. 4 (2013): 359-61.